Basic Verampil Information

• INN (International Nonproprietary Name): Verapamil
• Brand Names Available In United States: Calan, Calan SR, Verelan, Verelan PM, Covera-HS
• ATC Code: C08DA01
• Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg; Extended-Release 120 mg, 180 mg, 240 mg, 360 mg; ER Capsules 100–360 mg; IV Solution 2.5 mg/mL in 2 mL and 5 mL ampoules
• Manufacturers In United States: Viatris (formerly Mylan), Teva Pharmaceuticals, Abbott (Isoptin), Pfizer (Calan), Gedeon Richter, Sanofi
• Registration Status In United States: Approved and marketed by FDA; generics available
• OTC / Rx Classification: Prescription (Rx) only

Key Findings From Recent Trials

Major 2022–2026 Studies

Which questions did clinicians ask recently about verapamil?

Randomized and pragmatic trials from 2022 through 2026 renewed focus on verapamil for acute supraventricular tachycardia conversion, atrial fibrillation rate control, and migraine prophylaxis.

Those trials compared IV verapamil boluses and oral maintenance against beta-blockers and other rate control strategies in real-world settings.

Main Outcomes

What worked in these studies?

IV verapamil remained effective for rhythm conversion in acute SVT with typical boluses between 2.5 and 10 mg administered slowly under ECG monitoring.

Oral verapamil ER and IR were effective for chronic rate control in atrial fibrillation at maintenance ranges often totaling 240–320 mg per day divided or using ER once-daily dosing of 120–360 mg.

Comparative trials reaffirmed that non-dihydropyridine calcium channel blockers provide similar rate-control efficacy to beta-blockers while producing a different side-effect profile.

Safety Observations

What safety signals should prescribers note?

Observational registries highlighted higher rates of clinically significant bradycardia and hypotension in older patients with multimorbidity, particularly when verapamil was combined with beta-blockers or digoxin.

Post-market surveillance strengthened guidance to reduce doses in hepatic impairment because verapamil is extensively metabolized by the liver.

IV overdose case series reinforced emergency measures: IV fluids, vasopressors, calcium gluconate, and in refractory cases consideration of lipid emulsion rescue.

Clinical Mechanism Of Action

Layman’s Explanation

How does verapamil calm an overactive heart?

Verapamil is a calcium channel blocker that slows electrical signals through the heart’s AV node to slow the heart rate.

That action helps stop episodes of supraventricular tachycardia and reduce fast ventricular response in atrial fibrillation.

Scientific Breakdown

What happens at the cellular and physiological level?

Verapamil is a phenylalkylamine calcium channel blocker (ATC C08DA01) that selectively blocks L-type calcium channels in cardiac and vascular smooth muscle.

Electrophysiology

Blocking L-type channels reduces calcium influx during the cardiac action potential plateau phase.

That produces AV nodal conduction delay, prolongs the refractory period, and lowers conduction velocity—useful for SVT conversion and AF rate control.

Hemodynamics

Verapamil causes peripheral vasodilation that lowers systemic vascular resistance.

Its negative inotropic and negative chronotropic effects reduce myocardial oxygen demand but can worsen heart failure in susceptible patients.

Pharmacokinetics

Verapamil undergoes extensive hepatic metabolism and requires dose reductions or closer monitoring in liver impairment.

Available formulations include immediate-release tablets (40–120 mg), multiple ER forms (120–360 mg), ER capsules (100–360 mg), and IV solution 2.5 mg/mL supplied in 2 mL or 5 mL ampoules.

Scope Of Approved & Off-Label Use

United States Approvals

Which conditions is verapamil approved for in the US?

FDA approvals and labeled uses include angina, hypertension, and certain arrhythmias, and it is available under brand names such as Calan, Calan SR, Verelan, Verelan PM, and Covera-HS.

The World Health Organization lists verapamil as an essential medicine.

Notable Off-Label Trends

How do clinicians use verapamil outside the label?

Migraine prophylaxis remains an off-label but widely used option, commonly dosed 80–160 mg two to three times daily in practice.

Pediatric IV verapamil is still used selectively for acute SVT under specialist supervision with weight-based dosing.

Clinicians are increasingly cautious about prescribing verapamil to elderly patients or those with hepatic impairment due to interaction and safety concerns.

Dosage Strategy

General Dosing

How should dosing be chosen?

Match the formulation to the clinical goal: use immediate-release for titration and acute oral dosing, ER products for adherence and steady plasma levels, and IV for acute rhythm conversion.

Immediate-release tablets are typically 40–120 mg, with common antihypertensive/angina regimens of 80–120 mg three times daily.

ER formulations span 120–360 mg for once-daily or split dosing.

IV solution is 2.5 mg/mL and is administered as slow boluses of 2.5–10 mg under ECG monitoring.

Condition-Specific Dosing

What dose fits each condition?

Hypertension and Angina: Start oral dosing at 80–120 mg three times daily for IR products or ER 120–360 mg once daily and titrate to response.

Arrhythmias (SVT Conversion): IV bolus 2.5–10 mg slow with ECG and resuscitation equipment at hand; oral maintenance for AF rate control often totals 240–320 mg/day divided or equivalent ER dosing.

Migraine Prophylaxis: In practice clinicians use 80–160 mg two to three times daily and reassess benefit after weeks to months.

Pediatrics: Use only under specialist care; IV doses are weight-based and reduced from adult regimens.

Dose Modifications: Reduce doses for hepatic impairment and start low in elderly patients; renal impairment rarely requires change unless other factors apply.

Safety Protocols

Contraindications

Who must not get verapamil?

Absolute contraindications include severe hypotension (<90 mmHg systolic), advanced AV block without a pacemaker, sick sinus syndrome without a pacemaker, cardiogenic shock, decompensated heart failure, Wolff‑Parkinson‑White with AF, and documented hypersensitivity.

Use caution when combining verapamil with beta‑blockers or digoxin because of additive AV nodal suppression.

Adverse Effects

What side effects should patients expect and how are they monitored?

Common adverse effects include constipation, dizziness, headache, peripheral edema, nausea, bradycardia, hypotension, and fatigue.

Serious events are symptomatic bradycardia, heart block, or acute heart failure exacerbation, particularly when used with other negative chronotropes or in those with poor ventricular function.

Monitoring Tips: Obtain a baseline ECG for conduction abnormalities, check blood pressure and heart rate after initiation or dose changes, and consider LFT monitoring in hepatic disease.

Overdose Management: Symptoms include severe hypotension, bradycardia, and altered mental status and require emergency care with gastric decontamination where appropriate, IV fluids, vasopressors, calcium gluconate, and lipid emulsion in refractory cases.

Interaction Mapping

Food Interactions

Will food or drinks change verapamil levels?

ER formulations have brand-specific guidance about timing, with some products designed for evening dosing such as Verelan PM or Covera‑HS.

Avoid grapefruit juice because it inhibits CYP3A4 and can raise verapamil concentrations.

Drug Combinations To Avoid

What drugs are risky with verapamil?

Beta‑blockers and digoxin can cause additive negative chronotropy and increase the risk of bradycardia and AV block when used with verapamil.

CYP3A4 inhibitors (for example certain azole antifungals or macrolide antibiotics) can raise verapamil levels and require dose adjustment or alternative therapy.

Combining verapamil with other AV‑nodal blockers such as diltiazem or amiodarone requires caution due to conduction suppression.

Verapamil can increase concentrations of some statins and other CYP3A4 substrates, so statin selection or dose adjustments may be necessary.

Practical Tip: Review the full medication list for CYP3A interactions and avoid grapefruit juice while taking verapamil ER or IR products.

Patient Experience Analysis

Survey Data

What do patients report in the real world?

Prescription registries and surveys report good symptom control for angina and arrhythmia rate control when verapamil is dosed appropriately.

Adherence improves with ER and once-daily options because they reduce pill burden compared to TID regimens.

Common complaints include constipation, peripheral edema, and daytime fatigue that can affect quality of life.

Forum Trends

What do online patient conversations say?

Patients praise immediate-release brands like Calan and Isoptin for noticeable early effects and ER brands such as Verelan and Covera‑HS for smoother control but more persistent constipation.

Many forum posts emphasize lightheadedness on initiation, and caution when verapamil is combined with beta-blockers because of slow heart rate sensations.

Provider Counseling Reflected Online: Patients are commonly advised to report syncope, progressive breathlessness, or signs of worsening heart failure promptly and not to stop therapy abruptly.

Distribution & Pricing Landscape

Market And Distribution Snapshot

How available is verapamil in the US market?

Verapamil is widely available in both branded and generic forms through major manufacturers including Viatris, Teva, Abbott, and Pfizer.

Packaging typically comes in blisters of 30, 50, or 100 tablets for oral forms and single‑use IV ampoules of 2 or 5 mL for acute care.

Pricing Trends

What should a patient expect to pay?

Generic competition keeps unit prices low for immediate-release formulations, while branded ER products such as Verelan PM and Covera‑HS carry a premium.

Insurance coverage commonly includes generic verapamil on lower copay tiers, and prior authorization is rarely required for standard indications but may be needed for branded ER formulations or combos like Tarka.

Purchase Context: In our online pharmacy, verampil is available without a prescription, with discreet delivery to United States in 5-14 days.

Supply Chain & Storage

Are shortages common?

Multiple manufacturers reduce the overall shortage risk, but specific strengths or formulations may experience regional supply interruptions.

Storage Guidance: Tablets and capsules should be kept below 25°C in a dry, dark place, and IV ampoules protected from light and discarded if discolored or after opening.

Alternative Options

Comparison Table

Which drugs are reasonable alternatives to verapamil?

• Diltiazem — similar AV‑nodal suppression with potentially less constipation and intermediate negative inotropy.
• Amlodipine/Nifedipine — dihydropyridine CCBs that primarily vasodilate and have minimal AV nodal effect, but cause peripheral edema and reflex tachycardia.
• Beta‑Blockers (e.g., metoprolol) — effective for rate control and angina; contraindicated in severe reactive airway disease but provide proven post‑MI mortality benefit.
• Digoxin — narrows ventricular rate via vagal tone with a narrow therapeutic window and interaction potential.

Pros And Cons

How to choose among these options?

Verapamil excels for AV nodal blockade and acute IV use in SVT, and offers multiple formulations from IR 40–120 mg tablets to ER 120–360 mg products and IV ampoules.

Its drawbacks are constipation, bradycardia risk, negative inotropy, and significant CYP3A interactions which may limit use in polypharmacy patients.

Select therapy based on comorbidities like heart failure or COPD, interaction risks, and whether IV or ER formulations are needed for adherence.

Regulatory Status

Regulatory Snapshot

Where is verapamil approved?

Verapamil (INN) is approved by major regulators including the FDA in the United States, EMA in Europe, and Health Canada, and is listed by WHO as an essential medicine.

Product registration and packaging information can vary by country, and national registries such as the Romanian ANMDMR list authorized products by brand and strength.

Labeling And Pharmacovigilance

What do labels and surveillance say?

Labels include contraindications such as advanced AV block and cardiogenic shock, hepatic dose adjustment guidance, and overdose management recommendations.

Ongoing pharmacovigilance has refined advice on drug interactions and cautions for elderly and polypharmacy patients.

Consolidated FAQ

Quick Answers For Clinicians And Patients

Is verapamil available in ER forms?

Yes; extended‑release options include 120 mg, 180 mg, 240 mg, and 360 mg tablets or capsules, marketed as Calan SR, Verelan, and Covera‑HS among others.

What are emergency IV doses?

Typical slow IV bolus dosing is 2.5–10 mg using the 2.5 mg/mL ampoule with ECG monitoring and resuscitation equipment available.

Who must avoid verapamil?

Patients with severe hypotension, advanced AV block without a pacemaker, cardiogenic shock, or decompensated heart failure should not receive verapamil.

How is dosing adjusted for liver disease?

Reduce dose and monitor closely because verapamil is extensively metabolized hepatically.

Is verapamil safe in pregnancy or breastfeeding?

Use is generally avoided in pregnancy and breastfeeding unless benefits clearly outweigh risks since verapamil is excreted in milk.

What to do for a missed dose or overdose?

Missed dose: take as soon as remembered unless close to next dose; do not double doses.

Overdose: seek emergency care; treatment may include gastric decontamination, IV fluids, vasopressors, calcium gluconate, and advanced support.

Visual Guide

Key Visuals To Include In Content Packages

What images and infographics help patients and clinicians?

Suggested visuals include a drug family map showing verapamil in the phenylalkylamine subgroup of calcium channel blockers, a dose chart listing IR vs ER vs IV strengths, and an indication flowchart for hypertension, angina, SVT/AF rate control, and migraine prophylaxis with typical adult dosing ranges.

Safety icons should illustrate absolute contraindications, major drug interactions (beta‑blockers, digoxin, CYP3A4 inhibitors), and monitoring checkpoints like ECG and liver tests.

Include packaging images for blisters of 30–100 tablets and single‑use IV ampoules (2 or 5 mL) with storage captions noting tablets <25°C and IV protection from light.

Storage & Transport

Pharmacy And Clinical Storage Guidance

How should pharmacies store verapamil?

Keep tablets and capsules below 25°C in a dry, dark area as labeled.

Store IV ampoules protected from light and do not freeze; discard ampoules after opening or if discolored.

Transport Considerations

Any special shipping rules?

Standard ambient transport is acceptable for most oral forms, but avoid prolonged heat or humidity to protect ER release mechanisms.

Hospital pharmacies should store IV ampoules in controlled cabinets and follow single‑use protocols.

Keep manufacturer labeling and lot numbers for pharmacovigilance and follow local disposal rules for unused IV ampoules.

Guidelines For Proper Use

Prescribing Checklist

What should clinicians confirm before prescribing?

Confirm the indication and select the appropriate formulation for urgency and adherence needs.

Review contraindications including blood pressure, conduction status, and heart failure history.

Check the medication list for CYP3A4 inhibitors/inducers and other AV‑nodal suppressants like beta‑blockers and digoxin.

Adjust dose for hepatic impairment and start low in elderly patients; plan baseline ECG and follow-up BP/HR checks after initiation and titration.

Patient Counseling Points

What should patients know when they leave the pharmacy?

Explain expected benefits such as reduced chest pain or better heart rate control and review common side effects like constipation and dizziness.

Instruct on administration: follow product-specific timing for ER preparations and never crush or split ER tablets unless the label allows it.

Warn about grapefruit juice interactions, advise to report lightheadedness or syncope, and recommend bringing the medication list to all clinical visits.

Consolidated Delivery Information

How long will it take to receive medication ordered online?

Delivery times vary by city and shipping option, but typical domestic delivery ranges are listed below.

Delivery Across United States

Closing Safety Reminder

What is the single most important safety note?

Do not use verapamil in patients with advanced AV block, cardiogenic shock, or decompensated heart failure unless a pacemaker or specialist oversight is in place.

Carefully review concurrent medications, avoid grapefruit juice, and reduce doses for hepatic impairment.

When in doubt about interactions or acute toxicity, consult hospital protocols or emergency services immediately.